PET Image Exploration of Novel Tracer [68Ga]-FAPI-JNU Imaging Studies in Patients with Malignant Tumors

PET/CT imaging was performed about 1 hour after the patient was injected with the novel tracer 68Ga-FAPI-JNU. SUVmax and SUVmean values of the area of interest were mapped by two diagnostic physicians with more than 5 years of experience after the imaging was completed.

Inclusion criteria

• The subjects sign the informed consent voluntarily and can complete the test according to the protocol requirements;
• Age 18-85 years old, male or female;
• Clinically diagnosed as malignant tumor, diagnostic criteria refer to biopsy or other imaging such as CT and MRI;
• ECOG score is 0-3 points;

Exclusion criteria

• Patients with a history or allergic constitution to any component of the developer, including alcohol;
• pregnant or lactating women;
• Patients with mental illness or related history;
• Patients who cannot or cannot undergo a PET/CT scan;